These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 15523942
1. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure. Moga VD, Luca C, Luca CT, Branea H, Drăgulescu SI. Rom J Intern Med; 1999; 37(1):25-9. PubMed ID: 15523942 [Abstract] [Full Text] [Related]
2. Intermittent infusion of inotropes in the outpatient setting: one-year post treatment analysis. López-Candales A, Carron C, Graham S, Schwartz J. P R Health Sci J; 2000 Jun; 19(2):107-14. PubMed ID: 10909705 [Abstract] [Full Text] [Related]
3. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Marius-Nunez AL, Heaney L, Fernandez RN, Clark WA, Ranganini A, Silber E, Denes P. Am Heart J; 1996 Oct; 132(4):805-8. PubMed ID: 8831370 [Abstract] [Full Text] [Related]
4. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure. Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN. J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832 [Abstract] [Full Text] [Related]
5. Multidisciplinary outpatient congestive heart failure clinic: impact on hospital admissions and emergency room visits. Martineau P, Frenette M, Blais L, Sauvé C. Can J Cardiol; 2004 Oct; 20(12):1205-11. PubMed ID: 15494772 [Abstract] [Full Text] [Related]
6. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS. Am J Cardiol; 2007 Jul 01; 100(1):90-3. PubMed ID: 17599447 [Abstract] [Full Text] [Related]
7. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study. Elis A, Bental T, Kimchi O, Ravid M, Lishner M. Clin Pharmacol Ther; 1998 Jun 01; 63(6):682-5. PubMed ID: 9663183 [Abstract] [Full Text] [Related]
8. Intermittent intravenous amrinone infusion: a potentially cost effective mode of treatment of patients with refractory heart failure. Levinoff Roth SN, Moe G. Can J Cardiol; 1993 Apr 01; 9(3):231-7. PubMed ID: 8508332 [Abstract] [Full Text] [Related]
9. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure. Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S. J Cardiovasc Pharmacol Ther; 2007 Sep 01; 12(3):232-6. PubMed ID: 17875951 [Abstract] [Full Text] [Related]
10. Outpatient dobutamine for end-stage congestive heart failure. Miller LW, Merkle EJ, Herrmann V. Crit Care Med; 1990 Jan 01; 18(1 Pt 2):S30-3. PubMed ID: 2293976 [Abstract] [Full Text] [Related]
11. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up]. Conte MR, Mainardi L, Iazzolino E, Casetta M, Asteggiano R, Lai F, Lusardi R, Sasso L. Ital Heart J Suppl; 2005 Dec 01; 6(12):812-20. PubMed ID: 16444925 [Abstract] [Full Text] [Related]
12. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure. Roffman DS, Applefeld MM, Grove WR, Talesnick BS, Sutton FJ, Newman KA, Reed WP. Clin Pharm; 1985 Dec 01; 4(2):195-9. PubMed ID: 3987220 [Abstract] [Full Text] [Related]
13. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status? Winkel E, Kao W, Fisher SG, Heroux AL, Johnson MR, Costanzo MR. J Heart Lung Transplant; 1998 Aug 01; 17(8):809-16. PubMed ID: 9730431 [Abstract] [Full Text] [Related]
14. [Outpatient management program of patients with chronic heart failure]. Cacciatore G, Menichelli M, Albi F, De Lio L, Boccanelli A. G Ital Cardiol; 1998 Oct 01; 28(10):1106-12. PubMed ID: 9834862 [Abstract] [Full Text] [Related]
15. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Nanas JN, Papazoglou P, Tsagalou EP, Ntalianis A, Tsolakis E, Terrovitis JV, Kanakakis J, Nanas SN, Alexopoulos GP, Anastasiou-Nana MI. Am J Cardiol; 2005 Mar 15; 95(6):768-71. PubMed ID: 15757608 [Abstract] [Full Text] [Related]
16. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. Upadya S, Lee FA, Saldarriaga C, Verma S, Sedrakyan A, Nystrom K, Katz SD. J Heart Lung Transplant; 2004 Apr 15; 23(4):466-72. PubMed ID: 15063407 [Abstract] [Full Text] [Related]
17. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure. Arnold LM, Crouch MA, Carroll NV, Oinonen MJ. Pharmacotherapy; 2006 Aug 15; 26(8):1078-85. PubMed ID: 16863484 [Abstract] [Full Text] [Related]
18. Home inotropic therapy in children. Berg AM, Snell L, Mahle WT. J Heart Lung Transplant; 2007 May 15; 26(5):453-7. PubMed ID: 17449413 [Abstract] [Full Text] [Related]
19. [Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage]. Marcon JL, Bonijoly S, Favre E. Ann Cardiol Angeiol (Paris); 1993 Nov 15; 42(9):495-502. PubMed ID: 8122866 [Abstract] [Full Text] [Related]
20. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC. Circ Heart Fail; 2009 Jul 15; 2(4):320-4. PubMed ID: 19808355 [Abstract] [Full Text] [Related] Page: [Next] [New Search]